Glucosylsphingosine accumulation in patients with Gaucher disease.

被引：0
|
作者：
Orvisky, E [1 ]
Ginns, EI [1 ]
Sidransky, E [1 ]
机构：
[1] NIMH, DHHS, PHS, NIH, Bethesda, MD USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1999年 / 65卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
2421
引用
收藏
页码：A427 / A427
页数：1
相关论文
共 50 条
  • [41] Galactosylsphingosine does not interfere with the quantitation of plasma glucosylsphingosine levels in Gaucher patients
    Chuang, Wei-Lien
    Pacheco, Joshua
    Hoxha, Dritan
    Sanderink, Gerard
    Sung, Crystal
    CLINICA CHIMICA ACTA, 2019, 494 : 48 - 51
  • [42] Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy
    Nair, Shiny
    Bar, Noffar
    Xu, Mina L.
    Dhodapkar, Madhav
    Mistry, Pramod K.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (04) : 286 - 291
  • [43] Evaluation of glucosylsphingosine as a biomarker of the eliglustat treatment response in patients with Gaucher disease type 1 (GD1)
    Peterschmitt, M. Judith
    Zhang, Kate
    Liu, Lin
    Cox, Gerald F.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S94 - S95
  • [44] The role of glucosylsphingosine as an early indicator of disease progression in early symptomatic type 1 Gaucher disease
    Stiles, Ashlee R.
    Huggins, Erin
    Fierro, Luca
    Jung, Seung-Hye
    Balwani, Manisha
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2021, 27
  • [45] Article for pathologie Gaucher's disease.
    Epstein, E
    VIRCHOWS ARCHIV FUR PATHOLOGISCHE ANATOMIE UND PHYSIOLOGIE UND FUR KLINISCHE MEDIZIN, 1924, 253 (1/2): : 157 - 207
  • [46] Bone marrow scintigraphy in Gaucher disease.
    Aharoni, D
    Elstein, D
    Zimran, A
    Hadas-Halpern, I
    Chisin, R
    Krausz, Y
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 269P - 269P
  • [47] Correlation between Bone Disease and Genotype in Patients with Type 1 Gaucher Disease. Data from the Spanish Gaucher Disease Registry
    Andrade-Campos, Marcio
    Irun, Pilar
    Roca-Espiau, Mercedes
    Giraldo, Pilar
    BLOOD, 2017, 130
  • [48] Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients
    Rolfs, Arndt
    Giese, Anne-Katrin
    Grittner, Ulrike
    Mascher, Daniel
    Elstein, Deborah
    Zimran, Ari
    Boettcher, Tobias
    Lukas, Jan
    Huebner, Rayk
    Goelnitz, Uta
    Roehle, Anja
    Dudesek, Ales
    Meyer, Wolfgang
    Wittstock, Matthias
    Mascher, Hermann
    PLOS ONE, 2013, 8 (11):
  • [49] Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson ' s disease
    Marano, Massimo
    Zizzo, Carmela
    Malaguti, Maria Chiara
    Bacchin, Ruggero
    Cavallieri, Francesco
    De Micco, Rosa
    Spagnolo, Francesca
    Bentivoglio, Anna Rita
    Schirinzi, Tommaso
    Bovenzi, Roberta
    Ramat, Silvia
    Erro, Roberto
    Sorrentino, Cristiano
    Sucapane, Patrizia
    Pilotto, Andrea
    Lupini, Alessandro
    Magliozzi, Alessandro
    Di Vico, Ilaria
    Carecchio, Miryam
    Bonato, Giulia
    Cilia, Roberto
    Colucci, Fabiana
    Tamma, Filippo
    Caputo, Elena
    Mostile, Giovanni
    Arabia, Gennarina
    Modugno, Nicola
    Zibetti, Maurizio
    Ceravolo, Maria Gabriella
    Tambasco, Nicola
    Cossu, Giovanni
    Valzania, Franco
    Manganotti, Paolo
    Di Lazzaro, Vincenzo
    Zappia, Mario
    Fabbrini, Giovanni
    Tinazzi, Michele
    Tessitore, Alessandro
    Duro, Giovanni
    Di Fonzo, Alessio
    PARKINSONISM & RELATED DISORDERS, 2024, 124
  • [50] Substrate specificity and multiple tissue isoforms of glucocerebrosidase in patients with Gaucher disease.
    Orvisky, E
    Martin, BM
    Walker, JM
    Sidransky, E
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 455 - 455
12345